HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $55 Price Target
AnaptysBio, Inc. -2.80% Post
AnaptysBio, Inc. ANAB | 20.17 20.70 | -2.80% +2.63% Post |
HC Wainwright & Co. analyst Emily Bodnar reiterates AnaptysBio (NASDAQ:
ANAB) with a Buy and maintains $55 price target.